Keywords: Merck & Co, Tredaptive, Choleterol, EMA review, Dyslipedia, Lilly, Evacetrapib, Anacetrapib

EMA starts review of Merck & Co's cholesterol drug Tredaptive

Article | 24 December 2012

Print This

The European Medicines Agency said on December 21 that it has started a review of the safety and efficacy of US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in